LABORATORY RESEARCH Radiotherapy-Induced Plasticity of Prostate Cancer Mobilizes Stem-Like Non-Adherent, Erk Signaling-Dependent Cells Scientists explored radiation-induced stress response and heterogeneity of human metastatic prostate cancer cells, documented treatment-induced plasticity and phenotypically distinct cell subsets, and suggested the way to exploit their differential sensitivity to radiosensitizing drugs in overcoming radioresistance. [Cell Death Differ] Abstract Fbxo45-Mediated Degradation of the Tumor-Suppressor Par-4 Regulates Cancer Cell Survival Investigators demonstrate that Fbxo45 is the substrate-receptor subunit of a functional E3 ligase for prostate apoptosis response protein 4 (Par-4) that has a critical role in cancer cell survival. [Cell Death Differ] Abstract Androgen Deprivation Induces Phenotypic Plasticity and Promotes Resistance to Molecular Targeted Therapy in a PTEN-Deficient Mouse Model of Prostate Cancer Researchers used a PTEN-deficient mouse model of prostate cancer to show that plasticity in castration-resistant tumors promotes therapeutic escape. [Carcinogenesis] Abstract EpCAM Is Overexpressed in Local and Metastatic Prostate Cancer, Suppressed by Chemotherapy and Modulated by MET-Associated miRNA-200c/205 Investigators characterized epithelial cell adhesion molecule (EpCAM) expression on mRNA and protein level in comprehensive tissue studies including non-cancerous prostate specimens, primary tumors of different grades and stages, metastatic lesions, and therapy-treated tumor specimens, as well as in prostate cancer cell lines. [Br J Cancer] Abstract Combining the Pan-Aurora Kinase Inhibitor AMG 900 with Histone Deacetylase Inhibitors Enhances Antitumor Activity in Prostate Cancer Researchers used in vitro and in vivo xenograft models of prostate cancer (PCA) to test whether combination of histone deacetylase inhibitors with the pan-aurora kinase inhibitor AMG 900 can synergistically or additively kill PCA cells. [Cancer Med] Full Article Spheroid Culture of LuCaP 147 as an Authentic Preclinical Model of Prostate Cancer Subtype with SPOP Mutation and Hypermutator Phenotype Researchers demonstrate capabilities for high-throughput drug screening and that anti-cancer agents induced cell cycle arrest and apoptosis in spheroid cultures, and show that cells formed tumors when re-introduced into mice, providing an authentic in vitro – in vivo preclinical model of a subtype of prostate cancer with a hypermutator phenotype and an SPOP mutation. [Cancer Lett] Abstract Growth Hormone-Releasing Hormone Antagonists Abolish the Transactivation of Human Epidermal Growth Factor Receptors in Advanced Prostate Cancer Models The effects of growth hormone-releasing hormone (GHRH) in human epidermal growth factor receptor family members signaling were evaluated on human androgen-independent PC3 prostate cancer cells in vitro and GHRH antagonist in vitro and in nude mice xenografts of PC3 prostate cancer. [Invest New Drugs] Abstract Krüppel-Like Factor 4 Mediates Lysophosphatidic Acid-Stimulated Migration and Proliferation of PC3M Prostate Cancer Cells Scientists demonstrate that lysophosphatidic acid stimulates migration and proliferation of highly metastatic human prostate cancer, PC-3M-luc-C6 cells. [Exp Mol Med] Full Article CLINICAL RESEARCH Vasectomy and Risk of Aggressive Prostate Cancer: A 24-Year Follow-Up Study Conflicting reports remain regarding the association between vasectomy, a common form of male contraception in the United States, and prostate cancer risk. Researchers examined prospectively this association with extended follow-up and an emphasis on advanced and lethal disease. [J Clin Oncol] Abstract | Press Release Expression of Androgen and Estrogen Signaling Components and Stem Cell Markers to Predict Cancer Progression and Cancer-Specific Survival in Patients with Metastatic Prostate Cancer Genes of androgen and estrogen signaling and stem cell-like cells have crucial roles in prostate cancer (PC). Scientists aimed to predict clinical failure by estimating these PC-related genes. [Clin Cancer Res] Abstract |